• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

PLoS Pathogens. Unique Type I Interferon Responses Determine the Functional Fate of Migratory Lung Dendritic Cells during Influenza Virus Infection

Giuseppe

Emeritus
[Source: PLoS Pathogens, full text: (LINK). Abstract, edited.]

Unique Type I Interferon Responses Determine the Functional Fate of Migratory Lung Dendritic Cells during Influenza Virus Infection


‎by Bruno Moltedo, Wenjing Li, Jacob S. Yount, Thomas M. Moran


Migratory lung dendritic cells (DCs) transport viral antigen from the lungs to the draining mediastinal lymph nodes (MLNs) during influenza virus infection to initiate the adaptive immune response. Two major migratory DC subsets, CD103<SUP>+</SUP> DCs and CD11b<SUP>high</SUP> DCs participate in this function and it is not clear if these antigen presenting cell (APC) populations become directly infected and if so whether their activity is influenced by the infection. In these experiments we show that both subpopulations can become infected and migrate to the draining MLN but a difference in their response to type I interferon (I-IFN) signaling dictates the capacity of the virus to replicate. CD103<SUP>+</SUP> DCs allow the virus to replicate to significantly higher levels than do the CD11b<SUP>high</SUP> DCs, and they release infectious virus in the MLNs and when cultured ex-vivo. Virus replication in CD11b<SUP>high</SUP> DCs is inhibited by I-IFNs, since ablation of the I-IFN receptor (IFNAR) signaling permits virus to replicate vigorously and productively in this subset. Interestingly, CD103<SUP>+</SUP> DCs are less sensitive to I-IFNs upregulating interferon-induced genes to a lesser extent than CD11b<SUP>high</SUP> DCs. The attenuated IFNAR signaling by CD103<SUP>+</SUP> DCs correlates with their described superior antigen presentation capacity for na?ve CD8<SUP>+</SUP> T cells when compared to CD11b<SUP>high</SUP> DCs. Indeed ablation of IFNAR signaling equalizes the competency of the antigen presenting function for the two subpopulations. Thus, antigen presentation by lung DCs is proportional to virus replication and this is tightly constrained by I-IFN. The ?interferon-resistant? CD103<SUP>+</SUP> DCs may have evolved to ensure the presentation of viral antigens to T cells in I-IFN rich environments. Conversely, this trait may be exploitable by viral pathogens as a mechanism for systemic dissemination.
-
------
 
Back
Top